Ampio Pharmaceuticals SG&A Expense (Quarterly) Insights

Ampio Pharmaceuticals Inc (AMPE)

0.35 +0.06 (+22.38%) USD | OTCM | Apr 24, 16:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2008. Upgrade now.

Date	Value
December 31, 2023	0.973M
September 30, 2023	1.071M
June 30, 2023	1.216M
March 31, 2023	3.819M
December 31, 2022	1.962M
September 30, 2022	2.975M
June 30, 2022	3.245M
March 31, 2022	3.277M
December 31, 2021	4.491M
September 30, 2021	1.257M
June 30, 2021	1.40M
March 31, 2021	1.518M
December 31, 2020	1.762M
September 30, 2020	1.644M
June 30, 2020	1.479M
March 31, 2020	1.764M
December 31, 2019	1.649M
September 30, 2019	1.737M
June 30, 2019	1.423M
March 31, 2019	1.09M
December 31, 2018	0.9597M
September 30, 2018	0.7561M
June 30, 2018	1.017M
March 31, 2018	1.53M
December 31, 2017	1.376M

Date	Value
September 30, 2017	1.113M
June 30, 2017	1.341M
March 31, 2017	1.363M
December 31, 2016	1.307M
September 30, 2016	1.556M
June 30, 2016	1.563M
March 31, 2016	2.111M
December 31, 2015	2.87M
September 30, 2015	1.647M
June 30, 2015	2.666M
March 31, 2015	1.873M
December 31, 2014	-0.305M
September 30, 2014	3.299M
June 30, 2014	3.328M
March 31, 2014	2.659M
December 31, 2013	2.435M
September 30, 2013	1.536M
June 30, 2013	1.732M
March 31, 2013	1.312M
December 31, 2012	2.885M
September 30, 2012	0.678M
June 30, 2012	0.727M
March 31, 2012	1.536M
December 31, 2011	0.9602M
September 30, 2011	1.372M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.973M

Minimum

Dec 2023

4.491M

Maximum

Dec 2021

2.035M

Average

1.649M

Median

Dec 2019

SG&A Expense (Quarterly) Benchmarks